Home
Healthcare & Pharmaceuticals
Stem Cell Umbilical Cord Blood (UCB) Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Global Stem Cell Umbilical Cord Blood (UCB) Market by Applications (Regenerative Medicine and Transplant Medicine), Storage Service (Private Cord Blood Banks, Public Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Diabetes, Metabolic Disorders, Cancer, Immune Disorders, Blood Diseases, and Other), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

Report ID: HC-4548
Author: Growth Market Reports

Rating: 4.7
Total Reviews: 2

No. Of Pages: 187
Format:

Pub. Date: Upcoming
Share:

Report Description

The global stem cell umbilical cord blood (UCB) market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. After pregnancy or childbirth, cord blood is one of the richest sources of stem cells; however, this blood has enormous potential to treat chronic diseases such as cancer, diabetes, blood diseases, and immunological diseases. Stem cells derived from cord blood are utilized to treat a variety of rare diseases, including metabolic and immunological disorders.

Market Trends, Drivers, Restraints, and Opportunities:

Increasing demand for cord blood for the treatment of various diseases is fueling the market.
Rising investments in clinical trials and research by the government and private companies is expected to drive the demand for stem cell umbilical cord blood in the coming years.
High competition among players is expected to hamper the market growth.
Prevalence of diseases among people is anticipated to provide lucrative opportunities for market players during the forecast period.

Scope of the report:

The report on stem cell umbilical cord blood (UCB) market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes	Details
Report Title	Stem Cell Umbilical Cord Blood (UCB) Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Applications (Regenerative Medicine and Transplant Medicine), Storage Service (Private Cord Blood Banks, Public Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Diabetes, Metabolic Disorders, Cancer, Immune Disorders, Blood Diseases, and Other)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	CORDLIFE GROUP LIMITED, CBR Systems, Inc., MEDIPOST, Cryo-Cell International, Inc., Americord Registry LLC, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., ViaCord, Vita 34, Mesoblast Ltd, Caladrius Biosciences, Inc. and Pluristem Inc.

Stem Cell Umbilical Cord Blood (UCB) Market Segment Insights:

The private cord blood banks segment is projected to hold significant market share

In terms of storage service, the stem cell umbilical cord blood (UCB) market can be segmented into public cord blood banks, private cord blood banks, and hybrid cord blood banks. The private cord blood banks segment held a considerable share of the market in 2020 owing to increase in use of stem cells to treat diseases and to find accurate match for transfer.

The regenerative medicine segment held substantial market share in 2020

Based on applications, the stem cell umbilical cord blood (UCB) market can be bifurcated into regenerative medicine and transplant medicine. The regenerative medicine segment constituted a significant market share in 2020 and is projected to expand at a rapid rate during the forecast period.

The diabetes segment to grow during the forecast period

On the basis of therapeutics, the market can be segregated into diabetes, metabolic disorders, cancer, immune disorders, blood diseases, and others. The diabetes segment is expected to hold a significant share of the market during the forecast period due to growing research activities in pharmaceutical and biotechnological companies and increasing patients who are suffering from diabetes which ultimately drives the market.

North America dominates the global market

In terms of regions, the global stem cell umbilical cord blood (UCB) market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. Moreover, increase in R&D spending by pharmaceutical and biotechnology companies and growing healthcare infrastructure in the US are driving the market in North America. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing R&D expenditure and government initiatives in the field of stem cell umbilical cord blood market.

Segments

Storage Service

Private Cord Blood Banks
Public Cord Blood Banks
Hybrid Cord Blood Banks

Applications

Regenerative Medicine
Transplant Medicine

Therapeutics

Diabetes
Metabolic Disorders
Cancer
Immune Disorders
Blood Diseases
Others

By Regions

North America
Europe
Latin America
Asia Pacific
Middle East & Africa

Key Players

CORDLIFE GROUP LIMITED
CBR Systems, Inc.
MEDIPOST
Cryo-Cell International, Inc.
Americord Registry LLC
Global Cord Blood Corporation
LifeCell International Pvt. Ltd.
ViaCord
Vita 34
Mesoblast Ltd
Caladrius Biosciences, Inc.
Pluristem Inc.

Competitive Landscape

Key players in the stem cell umbilical cord blood (UCB) market include CORDLIFE GROUP LIMITED, CBR Systems, Inc., MEDIPOST, Cryo-Cell International, Inc., Americord Registry LLC, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., ViaCord, Vita 34, Mesoblast Ltd, Caladrius Biosciences, Inc. and Pluristem Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stem Cell Umbilical Cord Blood (UCB) Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Stem Cell Umbilical Cord Blood (UCB) Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Stem Cell Umbilical Cord Blood (UCB) Market - Supply Chain
  4.5. Global Stem Cell Umbilical Cord Blood (UCB) Market Forecast
     4.5.1. Stem Cell Umbilical Cord Blood (UCB) Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Stem Cell Umbilical Cord Blood (UCB) Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Stem Cell Umbilical Cord Blood (UCB) Market Absolute $ Opportunity
5. Global Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
6. North America Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
7. Latin America Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
8. Europe Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
9. Asia Pacific Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
10. Middle East & Africa Stem Cell Umbilical Cord Blood (UCB) Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Stem Cell Umbilical Cord Blood (UCB) Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Stem Cell Umbilical Cord Blood (UCB) Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Stem Cell Umbilical Cord Blood (UCB) Market: Market Share Analysis
  11.2. Stem Cell Umbilical Cord Blood (UCB) Distributors and Customers
  11.3. Stem Cell Umbilical Cord Blood (UCB) Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. CORDLIFE GROUP LIMITED
     11.4.2. CBR Systems, Inc.
     11.4.3. MEDIPOST
     11.4.4. Cryo-Cell International, Inc.
     11.4.5. Americord Registry LLC
     11.4.6. Global Cord Blood Corporation
     11.4.7. LifeCell International Pvt. Ltd.
     11.4.8.

Segments

Storage Service

Private Cord Blood Banks
Public Cord Blood Banks
Hybrid Cord Blood Banks

Applications

Regenerative Medicine
Transplant Medicine

Therapeutics

Diabetes
Metabolic Disorders
Cancer
Immune Disorders
Blood Diseases
Others

By Regions

North America
Europe
Latin America
Asia Pacific
Middle East & Africa

Key Players

CORDLIFE GROUP LIMITED
CBR Systems, Inc.
MEDIPOST
Cryo-Cell International, Inc.
Americord Registry LLC
Global Cord Blood Corporation
LifeCell International Pvt. Ltd.
ViaCord
Vita 34
Mesoblast Ltd
Caladrius Biosciences, Inc.
Pluristem Inc.

Compitive Landscape

Methodology

Add to Cart Request For Sample Enquiry Before Buying Speak With Analyst Request For Customization

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm